A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone
Clinical trial NCT03433001 · COMPLETED
Trial details
- NCT number
- NCT03433001
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-02
- Primary completion
- 2021-06-11
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.